Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MTSEA hydrobromide is a sulfhydryl-reactive compound that modifies free cysteine residues to produce a positively charged side chain similar in size to lysine.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | 35 days | $ 78.00 | |
50 mg | 35 days | $ 290.00 | |
100 mg | 35 days | $ 460.00 | |
250 mg | 35 days | $ 653.00 |
Description | MTSEA hydrobromide is a sulfhydryl-reactive compound that modifies free cysteine residues to produce a positively charged side chain similar in size to lysine. |
In vitro | Activation by Cd is occluded by modification with 2-aminoethyl MTS (MTSEA), indicating that Cd binds directly and specifically to the substituted cysteines.?Cd potency for the A657C mutation (EC50 = 10 M) suggests that binding involves at least two coordinating residues, whereas weaker Cd potency for L659C (EC50 = 2 mM) implies that activation does not require tight coordination by multiple side chains for this substitution.Cys modification by MTSEA reduces susceptibility to Cd activation of receptors with A8C or L10C substitutions[1]. |
Molecular Weight | 236.15 |
Formula | C3H10BrNO2S2 |
CAS No. | 16599-33-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MTSEA hydrobromide 16599-33-0 Others MTSEA Hydrobromide inhibitor inhibit